Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA, 5S ribosomal pseudogene 354 (RNA5SP354) is classified as a pseudogene corresponding to a defunct or nonfunctional copy of a 5S ribosomal RNA gene, lacking evidence for production of functional RNA or involvement in canonical ribosomal activity. 5S ribosomal RNA is a structural RNA component of the large ribosomal subunit and is critical to ribosome function, but pseudogenes such as RNA5SP354 typically do not produce functional RNA and accumulate mutations that render them transcriptionally or functionally inactive. RNA5SP354 has not been demonstrated to play a role as a therapeutic target, biomarker, or have known interactions with drugs. Its presence is primarily of genomic interest, useful for studies of genome evolution and pseudogene biology, rather than therapeutic or mechanistic research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 354 (RNA5SP354).